Rating Change
Canaccord Genuity analysts reiterated a Buy rating on Claritev Corporation (NYSE:CTEV) on July 21, 2026.
reiterateNYSE:CTEV
Canaccord Genuity Reiterates Buy Rating on Claritev Corporation (CTEV)
Rating Change Canaccord Genuity analysts reiterated a Buy rating on Claritev Corporation (NYSE:CTEV) on July 21, 2026. Market Context Claritev Corporation operates in the…
Market Context
Claritev Corporation operates in the Healthcare sector. The stock currently trades at $28.69 with a market capitalization of $641.2M.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Claritev Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Claritev Corporation
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| May 29, 2026 | Canaccord Genuity | Buy | N/A |
| Apr 24, 2026 | Barclays | Overweight | N/A |
| Mar 19, 2026 | Wells Fargo | Equal-Weight | N/A |
| Feb 25, 2026 | Citigroup | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CTEV Stock Page
Frequently Asked Questions
What does a Buy rating mean for CTEV?
A Buy rating from Canaccord Genuity reflects the analyst's outlook on Claritev Corporation (NYSE:CTEV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CTEV forecast page.